glp 1 in the brain Mechanisms of GLP-1 Modulating Craving and Addiction: Neurobiological and Translational Insights Frontiers | The mechanism and

In practice, some pharmacies sell it without a prescription, but this is technically against COFEPRIS regulations

Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway

While Ozempic is a GLP-1 agonist, Mounjaro is classified as a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, or dual GIP/GLP-1 agonist, meaning it targets an additional pathway to help control blood sugar (and as a side effect, help with weight loss)

Even more potent drugs, such as retatrutide and cagrisema, are in the clinical pipeline